Enovix (NASDAQ:ENVX – Get Free Report) had its target price lowered by research analysts at B. Riley from $18.00 to $16.00 in a report released on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. B. Riley’s target price indicates a potential upside of 146.53% from the company’s previous close.
A number of other research firms have also commented on ENVX. Cantor Fitzgerald restated an “overweight” rating and issued a $30.00 price objective on shares of Enovix in a research report on Thursday, April 25th. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $17.00 price target on shares of Enovix in a report on Wednesday, February 21st. Finally, JPMorgan Chase & Co. dropped their price objective on Enovix from $18.00 to $12.00 and set an “overweight” rating for the company in a research note on Friday. One investment analyst has rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $27.14.
Check Out Our Latest Stock Analysis on Enovix
Enovix Trading Up 0.5 %
Enovix (NASDAQ:ENVX – Get Free Report) last posted its earnings results on Tuesday, February 20th. The company reported ($0.35) earnings per share for the quarter, missing the consensus estimate of ($0.34) by ($0.01). The business had revenue of $7.38 million during the quarter, compared to analysts’ expectations of $3.37 million. Enovix had a negative return on equity of 77.74% and a negative net margin of 2,800.51%. As a group, research analysts forecast that Enovix will post -1.13 EPS for the current year.
Insider Buying and Selling at Enovix
In related news, COO Ajay Marathe sold 4,954 shares of the company’s stock in a transaction on Sunday, April 14th. The stock was sold at an average price of $7.31, for a total transaction of $36,213.74. Following the completion of the sale, the chief operating officer now owns 978,913 shares in the company, valued at $7,155,854.03. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 17.30% of the company’s stock.
Institutional Investors Weigh In On Enovix
A number of institutional investors and hedge funds have recently added to or reduced their stakes in ENVX. Allspring Global Investments Holdings LLC bought a new position in shares of Enovix in the third quarter worth about $31,000. Beacon Capital Management LLC lifted its position in shares of Enovix by 66.7% in the fourth quarter. Beacon Capital Management LLC now owns 2,500 shares of the company’s stock worth $31,000 after buying an additional 1,000 shares in the last quarter. Carmel Capital Partners LLC bought a new position in shares of Enovix during the 3rd quarter valued at approximately $34,000. Able Wealth Management LLC purchased a new position in shares of Enovix in the fourth quarter valued at $34,000. Finally, Quest Partners LLC bought a new position in Enovix during the fourth quarter valued at $49,000. Institutional investors own 50.92% of the company’s stock.
Enovix Company Profile
Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Featured Stories
- Five stocks we like better than Enovix
- 3 Stocks to Consider Buying in October
- Analyst Sentiment, Revenue Growth Will Lead AbbVie Stock Higher
- Roth IRA Calculator: Calculate Your Potential Returns
- 3 Trend-Following Entries for Income Investors
- What is the S&P 500 and How It is Distinct from Other Indexes
- 3 Stocks Mega Investors Are Buying
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.